RECURSION PHARMACEUTICALS, INC. reports $65.3 million Q1 loss

RECURSION PHARMACEUTICALS, INC. [RXRX] has reported fiscal Q1 loss of $65.30 million.

On a per-share basis, the DE based company said its diluted earnings are $0.34.

The Biological Products, Except Diagnostic Substances firm posted revenue of $12.10 million in this period.